CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
CVS Health Mulls Split Of Retail And Insurance Divisions To Address Financial Challenges: Report
This valuation gap underscores CVS's pressure to find a viable path forward amid growing competition and investor concerns.CVS Health Inc (NYSE:CVS) is reportedly considering a major restructuring that could involve separating its retail and insurance businesses.
西維斯健康公司（NYSE：CVS）據稱正在考慮進行一項可能涉及分離其零售和保險業務的重大重組。
The move comes as the healthcare services company faces investor pressure and seeks to recover from a challenging financial period.
此舉是因爲這家醫療服務公司面臨投資者壓力，並希望從一段具有挑戰性的財務時期中恢復過來。
CVS Health is trading at an EBITDA multiple of 7x, which is significantly lower than key competitors like UnitedHealth Inc (NYSE:UNH) and Cigna Inc (NYSE:CI), which trade at multiples of 14x and 9x, respectively.
西維斯健康的EBITDA倍數爲7倍，明顯低於主要競爭對手如聯合健康公司（紐交所：UNH）和西格瑪公司（紐交所：CI）的倍數分別爲14倍和9倍。
This valuation gap underscores CVS's pressure to find a viable path forward amid growing competition and investor concerns.
這種估值差距凸顯了西維斯面臨在激烈競爭和投資者關切中尋找可行發展路徑的壓力。
These talks with financial advisers explore how a potential breakup would work, although no final decisions have been made yet.
儘管尚未做出最終決定，但與財務顧問進行的討論探討了潛在分拆的運作方式。
Reuters report says the discussions, which remain confidential, include the possibility of unwinding CVS Health's $70 billion acquisition of Aetna in 2017, a deal that significantly expanded the company's insurance capabilities.
路透社報告稱，這些保持機密性的討論包括解除西維斯健康於2017年對埃特納（Aetna）的700億美元收購，這項交易顯著擴大了該公司的保險能力。
Now facing mounting difficulties in its retail and insurance sectors, CVS Health is assessing various strategies, including the potential split of its business units.
西維斯健康目前在其零售和保險業務領域面臨日益嚴峻的困境，正在評估各種策略，包括潛在分拆業務部門。
If the separation occurs, CVS Health could create two publicly traded companies, but the decision is pending approval from its board of directors.
如果分拆發生，西維斯健康可以創建兩家上市公司，但決定還在等待董事會的批准。
Another point of debate is whether CVS Health's pharmacy benefits manager (PBM) should remain part of the retail division or be integrated into the insurance segment.
關於西維斯健康的藥房福利經理（PBM）是否應該繼續作爲零售部門的一部分還是整合到保險領域存在爭議。
The final structure of any split will depend on internal deliberations, Although the Reuters report adds that CVS Health could still pursue a different approach.
任何分拆的最終結構將取決於內部討論，儘管路透社的報道稱西維斯健康仍然可能採取不同的方法。
As per a recent WSJ report, CVS Health is set to face renewed pressure as hedge fund Glenview Capital Management, led by founder Larry Robbins, plans to meet top executives, including CEO Karen Lynch, to discuss operational improvements.
根據最近的華爾街日報報道，西維斯健康將面臨重新加大壓力，由創始人拉里·羅賓斯領導的對沖基金Glenview Capital Management計劃與首席執行官Karen Lynch等高管會面，討論運營改進。
The meeting with Glenview comes as part of Robbins' broader strategy to push for change.
與Glenview的會議是羅賓斯推動變革策略的一部分。
In the second quarter, the pharmacy chain reported adjusted EPS of $1.83 decreased from $2.21 in the prior year, beating the consensus of $1.73.
在第二季度，這家藥店連鎖報告的調整後每股收益爲1.83美元，較去年的2.21美元下降，超過了1.73美元的共識。
The fall is primarily due to a decline in the Health Care Benefits segment's operating results, which reflect continued utilization pressure and the unfavorable impact of the company's Medicare Advantage star ratings for the 2024 payment year within the Medicare product line.
這一下降主要是由於醫療保健福利部門運營結果的下降，這反映了持續的利用壓力以及公司2024年度醫療保險產品線內醫保優質評級的不利影響。
CVS Health revised its adjusted EPS guidance to $6.40-$6.65 from at least $7.00 versus the consensus of $6.98, reflecting continued pressure in the Health Care Benefits segment.
西維斯健康調整後的每股收益指導值從至少7.00美元調整爲6.40-6.65美元，低於6.98美元的共識，反映了衛生保健福利部門持續的壓力。
CVS Health decided to make leadership changes based on the current performance and outlook for the Health Care Benefits segment.
西維斯健康決定根據醫療保健福利部門目前的業績和展望進行領導層變動。
Brian Kane quit, and Karen Lynch, the CEO, assumed direct leadership of the Health Care Benefits segment.
布賴恩·凱恩（Brian Kane）辭職，首席執行官卡倫·林奇（Karen Lynch）直接領導醫療保健福利部門。
Karen and Tom Cowhey, CVS Health's CFO, oversee the business's day-to-day management.
CVS健康的首席財務官湯姆·考維（Tom Cowhey）和卡倫共同監督業務的日常管理。
Price Action: At last check Tuesday, CVS stock was up 2.21% at $64.27 during the premarket session.
價格走勢：最後查看，西維斯健康股價在盤前交易會話中上漲2.21%，報64.27美元。
- SLB, ADNOC Drilling, Patterson-UTI Join Forces To Accelerate UAE's Unconventional Oil Program.
- SLb，阿布扎比國家石油公司鑽探，帕特森-UTI聯手加速阿聯酋的非常規油氣項目。
Image via Shutterstock
圖片來自shutterstock。
